Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antiviral
    (1)
  • Apoptosis
    (1)
  • Estrogen Receptor/ERR
    (2)
  • Estrogen/progestogen Receptor
    (2)
  • IL Receptor
    (2)
  • Interleukin
    (5)
  • JAK
    (1)
  • STAT
    (1)
  • Others
    (6)
Filter
Search Result
Results for "gp130" in TargetMol Product Catalog
  • Recombinant Protein
    30
    TargetMol | Activity
  • Inhibitor Products
    12
    TargetMol | inventory
GP130 receptor agonist-1
T9157339303-87-6
GP130 receptor agonist-1 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami) is a potent, brain-penetrant and orally active GP130 receptor agonist.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
JI069
T77672850019-35-1
JI069 (WAY-354189) is a potent STAT3 inhibitor that inhibits gp130 signaling by inducing dissociation between gp130 and JAK1.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
JAK2/STAT3-IN-1
T727542485758-50-5In house
JAK2/STAT3-IN-1 is a GP130 inhibitor with anti-tumor effects and can be used to study inflammation, autoimmunity and cancer.
  • $293 TargetMol
In Stock
Size
QTY
(R)-JAK2/STAT3-IN-10a
T72754L2485758-49-2
(R)-JAK2/STAT3-IN-10a is the R-isomer of JAK2/STAT3-IN-1.JAK2/STAT3-IN-1 is a GP130 D1 structural domain inhibitor with antitumor activity that inhibits the phosphorylation of JAK2 and STAT3. The KD value of (R)-JAK2/STAT3-IN-1 on GP130 protein is 3.8 μM.
  • $195 TargetMol
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Bazedoxifene hydrochloride
T6404198480-56-7
Bazedoxifene hydrochloride (TSE 424 hydrochloride) is an orally active, selective, and potent estrogen receptor modulator (SERM) that crosses the blood-brain barrier and is an inhibitor of IL-6 GP130 protein interactions with high affinity for ERα and ERβ. It has a high affinity for ERα and ERβ and can be used to study postmenopausal osteoporosis and vasodilator-related diseases.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Bazedoxifene acetate
T2544198481-33-3
Bazedoxifene acetate (WAY-TES 424) is a novel selective estrogen receptor modulator (SERM).
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
LMT-28
T157691239600-18-0
LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
SC144
T6207895158-95-9
SC144 is an orally active small-molecule gp130 inhibitor.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Truncated ADR58
T74734
Truncated ADR58, derived by shortening full-length ADR58 from 71 bases to 31 bases, maintains comparable functional activity to its full-length counterpart. This compound acts as a potent and selective antagonist of human oncostatin M (OSM), effectively blocking OSM's interaction with the gp130 receptor and inhibiting OSM-mediated signaling. It is utilized in studying diseases related to rheumatoid arthritis [1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
SC144 hydrochloride
T41260917497-70-2
SC144 hydrochloride, a first-in-class, orally active, small-molecule gp130 (IL6-beta) inhibitor, demonstrates potent inhibition of gp130 ligand-triggered signaling. By binding to gp130, it initiates gp130 phosphorylation (S782) and deglycosylation, impedes Stat3 phosphorylation and nuclear translocation, and suppresses the expression of downstream target genes. Furthermore, SC144 hydrochloride effectively induces apoptosis in human ovarian cancer cells [1].
  • $53
5 days
Size
QTY
RCGD423
T5359108237-91-8
RCGD423, a small molecule gp130 modulator, prevents articular cartilage degeneration and promotes repair.
  • $31
In Stock
Size
QTY
SPRC
T197283262-64-4
SPRC is a novel synthetic molecule exerting antioxidant effects via elevating the generation of endogenous H2S. SPRC activates Gp130-mediated STAT3 and prevents doxorubicin-induced cardiotoxicity.
  • $1,520
6-8 weeks
Size
QTY